1-methyltryptophan has been researched along with Colitis, Granulomatous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvisi, C; Badulli, C; Bernardo, ME; Betti, E; Bozzi, V; Cangemi, GC; Cervio, M; Ciccocioppo, R; Corazza, GR; Dionigi, P; Gallia, A; Gobbi, P; Gurrado, A; Kruzliak, P; Martinetti, M; Monti, M; Pecci, A; Picone, C; Visai, L | 1 |
1 other study(ies) available for 1-methyltryptophan and Colitis, Granulomatous
| Article | Year |
|---|---|
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Surface; Apoptosis; Bone Marrow Cells; Cell Proliferation; Cell Survival; Cells, Cultured; Coculture Techniques; Crohn Disease; Cytokines; Female; HLA-G Antigens; Humans; Immunophenotyping; Indoleamine-Pyrrole 2,3,-Dioxygenase; Intestinal Mucosa; Male; Mesenchymal Stem Cells; Middle Aged; RNA Interference; RNA, Small Interfering; T-Lymphocytes; Time-Lapse Imaging; Tryptophan; Young Adult | 2015 |